Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Schentag

Showing results (91-100 of 236) with videos related to

Pageof 24
Sort By:
Clinical Chemistry|May 1, 1985
Liquid-chromatographic determination of ciprofloxacin in serum and urineD E Nix, J M De Vito, J J Schentag
Archives of Surgery (Chicago, Ill. : 1960)|March 1, 1984
C-reactive protein as an indicator of infection relapse in patients with abdominal sepsisJ J Schentag, D O'Keeffe, M Marmion, et al.
European Journal of Clinical Pharmacology|January 1, 1984
The bioavailability and pharmacokinetics of cimetidine and its metabolites in juvenile cystic fibrosis patients: age related differences as compared to adultsJ A Ziemniak, B M Assael, R Padoan, et al.
Clinical Pharmacy|November 1, 1982
Cimetidine bioavailability after massive small bowel resectionJ Russo, W A Watson, E W Nelson, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Comparison of two methods for determining in vitro postantibiotic effects of three antibiotics on Escherichia coliD L Rescott, D E Nix, P Holden, et al.
Journal of Pharmaceutical Sciences|May 1, 1986
Pharmacokinetics of ketoconazole administered intravenously to dogs and orally as tablet and solution to humans and dogsJ G Baxter, C Brass, J J Schentag, et al.
The New England Journal of Medicine|June 17, 1982
Possible alteration of metronidazole metabolism by phenobarbitalP B Mead, M Gibson, J J Schentag, et al.
The Annals of Pharmacotherapy|January 1, 1992
Dose-ranging pharmacokinetic study of ciprofloxacin after 200-, 300-, and 400-mg intravenous dosesD E Nix, J M Spivey, A Norman, et al.
Journal of Toxicology. Clinical Toxicology|January 1, 1987
Repeated oral doses of activated charcoal and the clearance of tobramycin, a non-absorbable drugW A Watson, T C Jenkins, N Velasquez, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1989
Effect of oral antacid administration on the pharmacokinetics of intravenous doxycyclineV X Nguyen, D E Nix, S Gillikin, et al.
Pageof 24

Showing results (91-100 of 236) with videos related to

Sort By:
Pageof 24
Clinical Chemistry|May 1, 1985
Liquid-chromatographic determination of ciprofloxacin in serum and urineD E Nix, J M De Vito, J J Schentag
Archives of Surgery (Chicago, Ill. : 1960)|March 1, 1984
C-reactive protein as an indicator of infection relapse in patients with abdominal sepsisJ J Schentag, D O'Keeffe, M Marmion, et al.
European Journal of Clinical Pharmacology|January 1, 1984
The bioavailability and pharmacokinetics of cimetidine and its metabolites in juvenile cystic fibrosis patients: age related differences as compared to adultsJ A Ziemniak, B M Assael, R Padoan, et al.
Clinical Pharmacy|November 1, 1982
Cimetidine bioavailability after massive small bowel resectionJ Russo, W A Watson, E W Nelson, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Comparison of two methods for determining in vitro postantibiotic effects of three antibiotics on Escherichia coliD L Rescott, D E Nix, P Holden, et al.
Journal of Pharmaceutical Sciences|May 1, 1986
Pharmacokinetics of ketoconazole administered intravenously to dogs and orally as tablet and solution to humans and dogsJ G Baxter, C Brass, J J Schentag, et al.
The New England Journal of Medicine|June 17, 1982
Possible alteration of metronidazole metabolism by phenobarbitalP B Mead, M Gibson, J J Schentag, et al.
The Annals of Pharmacotherapy|January 1, 1992
Dose-ranging pharmacokinetic study of ciprofloxacin after 200-, 300-, and 400-mg intravenous dosesD E Nix, J M Spivey, A Norman, et al.
Journal of Toxicology. Clinical Toxicology|January 1, 1987
Repeated oral doses of activated charcoal and the clearance of tobramycin, a non-absorbable drugW A Watson, T C Jenkins, N Velasquez, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1989
Effect of oral antacid administration on the pharmacokinetics of intravenous doxycyclineV X Nguyen, D E Nix, S Gillikin, et al.
Pageof 24